EPO Patents = 2

Forward Citations = 6

Loading Chart...

4 inventors (with patents filed for the assignee):

Joanne Holland (7 out of 15 patents)

Christopher Frampton (6 out of 12 patents)

Daniel Gooding (5 out of 7 patents)

4. Alan Chorlton (5 out of 5 patents)

7 patents: Sort by Forward Citations

1. 9822066 - Tranilast compositions and cocrystals (2017-11-21),

2. 9532993 - Aprepitant L-proline solvates—compositions and cocrystals (2017-01-03),

3. 9512064 - Tranilast compositions and cocrystals (2016-12-06),

4. 9248196 - Rebamipide complexes and cocrystals (2016-02-02),

5. 9029369 - Aprepitant L-proline composition and cocrystal (2015-05-12),

6. 8871793 - Metaxalone cocrystals (2014-10-28),

7. 8779146 - Cilostazol cocrystals and compositions (2014-07-15),

Nuformix Limited is a pharmaceutical development company focused on discovering and developing new uses for existing drugs through cocrystal technology. Their innovative approach has the potential to create novel formulations that improve drug efficacy, safety, and patient outcomes. Nuformix aims to address unmet medical needs and create value for patients, partners, and shareholders through their research and development efforts.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Dec 2 2025

7 Patents

#197 in

#2,284 in United Kingdom

GB

Nuformix Limited

Forward Citations = 6

4 inventors:

Joanne Holland (7 out of 15 patents)

Christopher Frampton (6 out of 12 patents)

Daniel Gooding (5 out of 7 patents)

4. Alan Chorlton (5 out of 5 patents)

Please report any incorrect information to support@idiyas.com

2 patents (EPO):

Please report any incorrect information to support@idiyas.com